Company Profile
NKGen Biotech, Inc. Stock Price, News & Analysis
- Ticker:
- NKGN
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, NKGen Biotech is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
0.06 USD (0.00%)
Close
Last updated: June 18, 2026 at 00:00
—
Market cap
Why the stock is moving
NKGN is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
NKGen Biotech is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, NKGen Biotech is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
NKGen Biotech follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, NKGen Biotech sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of NKGen Biotech, Inc. (NKGN)?
NKGen Biotech, Inc. (NKGN) most recently closed at 0.06 USD, a 0.00% move versus the previous session.
What does NKGen Biotech, Inc. do?
NKGen Biotech is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is NKGN stock listed?
NKGen Biotech, Inc. (NKGN) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, NKGen Biotech is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is NKGen?
NKGen Biotech is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is NKGen Biotech, Inc. targeting with NKGen?
NKGen Biotech is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Biotech?
NKGen Biotech is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.